Market Research Logo

Global Cervical Dystonia Therapeutics Market 2019-2023

Global Cervical Dystonia Therapeutics Market 2019-2023

About this market

With the rise in reimbursement programs for botulinum neurotoxin injections, there is a growing demand for treatment of cervical dystonia. Several reimbursement programs are available to help people access the high-cost botulinum neurotoxin therapy for the treatment of cervical dystonia. These reimbursement programs help patients with or without medical insurance to achieve appropriate reimbursement for their treatment with botulinum toxins. For instance, Allergan, the manufacturer of BOTOX, sponsors a comprehensive reimbursement program called as BOTOX Reimbursement Solutions Program. This program includes a BOTOX Hotline and BOTOX Patient Assistance Program to assist patients who are receiving BOTOX injection treatment. Technavio’s analysts have predicted that the cervical dystonia therapeutics market will register a CAGR of almost 5% by 2023.Market Overview

Expected approval of late-stage pipeline molecules

The global cervical dystonia therapeutics industry is forecasted to witness a steady growth owing to the expected approval of late-stage molecules in the pipeline for the treatment of cervical dystonia. The cervical dystonia therapeutics market is also expected to benefit from the growing number of molecules being launched for the treatment of the disease.

Availability of alternate therapies

For the treatment of cervical dystonia, botulinum toxins and other therapeutics are used. However, the low rate of success and temporary cure of these therapeutics leads people towards alternative therapies such as DBS surgery, which is a major challenge for the growth of the market.

For the detailed list of factors that will drive and challenge the growth of the cervical dystonia therapeutics market during the 2019-2023 period, view our report.

Competitive Landscape

The market appears to be fragmented and with the presence of several companies including Allergan and Eisai, the competitive environment is quite intense. Factors such as the rising number of reimbursement programs for botulinum neurotoxin injections and the anticipated approval of late-stage pipeline molecules, will provide considerable growth opportunities to cervical dystonia therapeutic vendors. Allergan, Eisai, Ipsen Pharma, Merz Pharma, and US WorldMeds are some of the major companies covered in this report.


PRESS RELEASE

Technavio Announces the Publication of its Research Report - Global Cervical Dystonia Therapeutics Market 2019-2023

Technavio recognizes the following companies as the key players in the global cervical dystonia therapeutics market: Allergan, Eisai, Ipsen Pharma, Merz Pharma, and US WorldMeds.

Commenting on the report, an analyst from Technavio’s team said: “One trend affecting this market is the reimbursement for botulinum neurotoxin injections. Several reimbursement programs are available to help people access the high-cost botulinum neurotoxin therapy for the treatment of cervical dystonia. These reimbursement programs help patients with or without medical insurance to achieve appropriate reimbursement for their treatment with botulinum toxins.”

According to the report, one driver influencing this market is the expected approval of late-stage pipeline molecules. As the market is witnessing an acute lack of more approved cervical dystonia therapeutics, these late-stage pipelines molecules have the potential to tap the unmet demand from the patient pool for treatment of cervical dystonia.

Further, the report states that one challenge affecting this market is the product withdrawals. The global sepsis therapeutics market has an acute lack of approved therapies, resulting in huge unmet needs among sepsis patients and hampering the growth of the market.

Companies Mentioned

Allergan

Eisai

Ipsen Pharma

Merz Pharma

US WorldMeds

  • Executive summary
  • Scope of the report
  • Market landscape
    • Market ecosystem
      • Table Global CNS therapeutics market
      • Table Segments of global CNS therapeutics market
    • Market characteristics
      • Table Market characteristics
    • Market segmentation analysis
      • Table Market segments
  • Market sizing
    • Market definition
      • Table Market definition - Inclusions and exclusions checklist
    • Market sizing 2018
      • Table Market size 2018
    • Market size and forecast 2018-2023
      • Table Global market: Size and forecast 2018-2023 ($ millions)
      • Table Global market: Year-over-year growth 2019-2023 (%)
  • Five forces analysis
    • Table Five forces analysis 2018
    • Table Five forces analysis 2023
    • Bargaining power of buyers
      • Table Bargaining power of buyers
    • Bargaining power of suppliers
      • Table Bargaining power of suppliers
    • Threat of new entrants
      • Table Threat of new entrants
    • Threat of substitutes
      • Table Threat of substitutes
    • Threat of rivalry
      • Table Threat of rivalry
    • Market condition
      • Table Market condition - Five forces 2018
  • Market segmentation by product
    • Table Product - Market share 2018-2023 (%)
    • Comparison by product
      • Table Comparison by product
    • Botulinum toxins - Market size and forecast 2018-2023
      • Table Botulinum toxins - Market size and forecast 2018-2023 ($ millions)
      • Table Botulinum toxins - Year-over-year growth 2019-2023 (%)
    • Other therapeutics - Market size and forecast 2018-2023
      • Table Other therapeutics - Market size and forecast 2018-2023 ($ millions)
      • Table Other Therapeutics - Year-over-year growth 2019-2023 (%)
    • Market opportunity by product
      • Table Market opportunity by product
  • Customer landscape
    • Table Customer landscape
  • Geographic landscape
    • Geographic segmentation
      • Table Market share by geography 2018-2023 (%)
    • Geographic comparison
      • Table Geographic comparison
    • Americas - Market size and forecast 2018-2023
      • Table Americas - Market size and forecast 2018-2023 ($ millions)
      • Table Americas - Year-over-year growth 2019-2023 (%)
      • Table Top 3 countries in Americas
    • EMEA - Market size and forecast 2018-2023
      • Table EMEA - Market size and forecast 2018-2023 ($ millions)
      • Table EMEA - Year-over-year growth 2019-2023 (%)
      • Table Top 3 countries in EMEA
    • APAC - Market size and forecast 2018-2023
      • Table APAC - Market size and forecast 2018-2023 ($ millions)
      • Table APAC - Year-over-year growth 2019-2023 (%)
      • Table Top 3 countries in APAC
    • Key leading countries
      • Table Key leading countries
    • Market opportunity
      • Table Market opportunity
  • Decision framework
  • Drivers and challenges
    • Market drivers
    • Market challenges
      • Table Impact of drivers and challenges
  • Market trends
  • Vendor landscape
    • Overview
      • Table Vendor landscape
    • Landscape disruption
      • Table Landscape disruption
    • Competitive scenario
  • Vendor analysis
    • Vendors covered
      • Table Vendors covered
    • Vendor classification
      • Table Vendor classification
    • Market positioning of vendors
      • Table Market positioning of vendors
    • ALLERGAN
      • Table ALLERGAN - Vendor overview
      • Table ALLERGAN - Business segments
      • Table ALLERGAN - Organizational developments
      • Table ALLERGAN - Geographic focus
      • Table ALLERGAN - Segment focus
      • Table ALLERGAN - Key offerings
      • Table ALLERGAN - Key customers
    • Eisai
      • Table Eisai - Vendor overview
      • Table Eisai - Business segments
      • Table Eisai - Organizational developments
      • Table Eisai - Geographic focus
      • Table Eisai - Segment focus
      • Table Eisai - Key offerings
      • Table Eisai - Key customers
    • Ipsen Pharma
      • Table Ipsen Pharma - Vendor overview
      • Table Ipsen Pharma - Business segments
      • Table Ipsen Pharma - Organizational developments
      • Table Ipsen Pharma - Geographic focus
      • Table Ipsen Pharma - Segment focus
      • Table Ipsen Pharma - Key offerings
      • Table Ipsen Pharma - Key customers
    • Merz Pharma
      • Table Merz Pharma - Vendor overview
      • Table Merz Pharma - Business segments
      • Table Merz Pharma - Organizational developments
      • Table Merz Pharma - Geographic focus
      • Table Merz Pharma - Segment focus
      • Table Merz Pharma - Key offerings
      • Table Merz Pharma - Key customers
    • US WorldMeds
      • Table US WorldMeds - Vendor overview
      • Table US WorldMeds - Organizational developments
      • Table US WorldMeds - Key offerings
      • Table US WorldMeds - Key customers
  • Appendix
    • Research methodology
    • List of abbreviations
  • Explore Technavio

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report